Divi’s Laboratories Limited has announced that a meeting of its Board of Directors is scheduled for May 23, 2026. The board will review the company’s financial performance for the final quarter and the full fiscal year ended March 31, 2026. Furthermore, the meeting will address potential dividend recommendations for equity shareholders for the financial year 2025-26. The company has also confirmed that its trading window will remain closed until May 25, 2026.
Financial Results and Dividend Review
Divi’s Laboratories is set to convene its Board of Directors on May 23, 2026, to evaluate the company’s operational and financial results. During this session, the board will consider and approve both the standalone and consolidated financial statements for the quarter and year ended March 31, 2026.
In addition to the financial review, the board will deliberate on recommending a dividend for equity shareholders for the financial year 2025-26. Any final decision regarding the dividend payout will be communicated to the exchanges following the board meeting.
Trading Window Closure
The company previously notified stakeholders that the trading window for dealing in its securities was closed effective April 1, 2026. To ensure compliance and maintain market transparency during the earnings announcement period, this restriction will remain in effect until May 25, 2026, which is 48 hours after the official declaration of the financial results.
Source: BSE
